123 related articles for article (PubMed ID: 9641240)
1. nm23 expression in carcinoma of the uterine cervix.
Saraç E; Ayhan A; Ertoy D; Tuncer ZS; Yasui W; Tahara E; Ayhan A
Eur J Gynaecol Oncol; 1998; 19(3):312-5. PubMed ID: 9641240
[TBL] [Abstract][Full Text] [Related]
2. Altered expression of nm23-H1 and c-erbB-2 proteins have prognostic significance in adenocarcinoma but not in squamous cell carcinoma of the uterine cervix.
Mandai M; Konishi I; Koshiyama M; Komatsu T; Yamamoto S; Nanbu K; Mori T; Fukumoto M
Cancer; 1995 May; 75(10):2523-9. PubMed ID: 7736397
[TBL] [Abstract][Full Text] [Related]
3. [Relationship between nm23-H1 expression and lymph node metastasis and prognosis in cervical cancer].
Huang Y; Cai S; Yu S
Zhonghua Fu Chan Ke Za Zhi; 1997 Dec; 32(12):718-21. PubMed ID: 9772433
[TBL] [Abstract][Full Text] [Related]
4. Prognostic value of nm23 expression in stage IB1 cervical carcinoma.
Chen HY; Hsu CT; Lin WC; Tsai HD; Chang WC
Jpn J Clin Oncol; 2001 Jul; 31(7):327-32. PubMed ID: 11518746
[TBL] [Abstract][Full Text] [Related]
5. nm23 protein expression in colorectal carcinoma metastasis in regional lymph nodes and the liver.
Sarris M; Lee CS
Eur J Surg Oncol; 2001 Mar; 27(2):170-4. PubMed ID: 11289754
[TBL] [Abstract][Full Text] [Related]
6. Expression of nm23 in gastric carcinoma: association with tumor progression and poor prognosis.
Müller W; Schneiders A; Hommel G; Gabbert HE
Cancer; 1998 Dec; 83(12):2481-7. PubMed ID: 9874452
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical expression of nm23 gene product, nucleotide diphosphate kinase, in pancreatic neoplasms.
Ohshio G; Imamura T; Okada N; Suwa H; Yamaki K; Imamura M; Ogasahara K; Tsukayama C; Yamabe H
Int J Pancreatol; 1997 Aug; 22(1):59-66. PubMed ID: 9387026
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of the prognostic significance of nm23/NDP kinase protein expression in cervical carcinoma: an immunohistochemical study.
Kristensen GB; Holm R; Abeler VM; Tropé CG
Gynecol Oncol; 1996 Jun; 61(3):378-83. PubMed ID: 8641619
[TBL] [Abstract][Full Text] [Related]
9. nm23--relationship to the metastatic potential of breast carcinoma cell lines, primary human xenografts, and lymph node negative breast carcinoma patients.
Russell RL; Geisinger KR; Mehta RR; White WL; Shelton B; Kute TE
Cancer; 1997 Mar; 79(6):1158-65. PubMed ID: 9070493
[TBL] [Abstract][Full Text] [Related]
10. Immunoreactivities of human nonmetastatic clone 23 and p53 products are disassociated and not good predictors of lymph node metastases in early-stage cervical cancer patients.
Tee YT; Wang PH; Ko JL; Chen GD; Chang H; Lin LY
Eur J Gynaecol Oncol; 2007; 28(1):18-22. PubMed ID: 17375700
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of immunostaining for MIB1 and nm23 products in uterine cervical adenocarcinoma.
Morimura Y; Yanagida K; Hashimoto T; Takano Y; Watanabe F; Yamada H; Sato A
Tohoku J Exp Med; 1998 Jul; 185(3):185-97. PubMed ID: 9823779
[TBL] [Abstract][Full Text] [Related]
12. nm23 Protein expression in larynx cancer and the relationship with metastasis.
Gunduz M; Ayhan A; Gullu I; Onerci M; Hosal AS; Gursel B; Hosal IN; Firat D
Eur J Cancer; 1997 Dec; 33(14):2338-41. PubMed ID: 9616278
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical analysis of nm23-H1 gene product in node-positive lung cancer and lymph nodes.
Tomita M; Ayabe T; Matsuzaki Y; Onitsuka T
Lung Cancer; 1999 Apr; 24(1):11-6. PubMed ID: 10403689
[TBL] [Abstract][Full Text] [Related]
14. H-ras and Nm23-H1 gene expression and proteolytic activity in squamous cell carcinoma of the uterine cervix.
Utrera-Barillas D; Salcedo-Vargas M; Gariglio-Vidal P; Hernández-Hernández DM; Gutiérrez-Delgado F; Benítez-Bribiesca L
Arch Med Res; 2000; 31(2):172-81. PubMed ID: 10880723
[TBL] [Abstract][Full Text] [Related]
15. Elevated nm23 protein expression is correlated with diminished progression-free survival in patients with epithelial ovarian carcinoma.
Srivatsa PJ; Cliby WA; Keeney GL; Dodson MK; Suman VJ; Roche PC; Podratz KC
Gynecol Oncol; 1996 Mar; 60(3):363-72. PubMed ID: 8774640
[TBL] [Abstract][Full Text] [Related]
16. nm23-H1 expression in nasopharyngeal carcinoma: correlation with clinical outcome.
Guo X; Min HQ; Zeng MS; Qian CN; Huang XM; Shao JY; Hou JH
Int J Cancer; 1998 Dec; 79(6):596-600. PubMed ID: 9842967
[TBL] [Abstract][Full Text] [Related]
17. Nm23 expression in endometrial and cervical cancer: inverse correlation with lymph node involvement and myometrial invasion.
Marone M; Scambia G; Ferrandina G; Giannitelli C; Benedetti-Panici P; Iacovella S; Leone A; Mancuso S
Br J Cancer; 1996 Oct; 74(7):1063-8. PubMed ID: 8855975
[TBL] [Abstract][Full Text] [Related]
18. nm23 protein expression in fine-needle aspirates from breast carcinoma: inverse correlation with cytologic grading, lymph node status, and ploidy.
Sauer T; Furu I; Beraki K; Jebsen PW; Ormerod E; Naess O
Cancer; 1998 Apr; 84(2):109-14. PubMed ID: 9570214
[TBL] [Abstract][Full Text] [Related]
19. The association between nm23-H1 expression and survival in patients with esophageal squamous cell carcinoma.
Iizuka N; Tangoku A; Hayashi H; Yosino S; Abe T; Morioka T; Oka M
Cancer Lett; 1999 Apr; 138(1-2):139-44. PubMed ID: 10378785
[TBL] [Abstract][Full Text] [Related]
20. The significance of metastasis-related factors cathepsin-D and nm23 in advanced ovarian cancer.
Baekelandt M; Holm R; Tropé CG; Nesland JM; Kristensen GB
Ann Oncol; 1999 Nov; 10(11):1335-41. PubMed ID: 10631462
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
